In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Abu Dhabi - UAE

ESC in Abu Dhabi at the Asian Pacific Society of Cardiology Congress

Add to calendar29/04/20150:00 02/05/20150:00 Europe/Paris Abu Dhabi - UAE

The 'ESC in Abu Dhabi' programme is part of a series of international ESC educational courses built around a global network of international partnerships.

contact@escardio.org true DD/MM/YYYY
In-person
event
Abu Dhabi - UAE


Summary

The 'ESC in Abu Dhabi' programme is part of a series of international ESC educational courses built around a global network of international partnerships.

Focus on

Key topics covered included Heart failure cardiomyopathy, Arrhythmias, Valve disease, Imaging, Interventional cardiology and Risk factors.

THANK YOU ALL FOR ATTENDING 'ESC IN ABU DHABI' SCIENTIFIC SESSIONS

 

 

APSC Leadership and ESC Leadership

(From left to right): Prof S. Kristensen, Prof M. Komajda, Prof F. Pinto (ESC President), Prof J. Bax (ESC President-Elect)

Thursday 30 April

Room ICC Hall 2

08:00-10:00 Take home messages from ESC Congress 2014- Part I

Chairpersons: F. Pinto (Lisbon, Portugal), Dr Sim (APSC President)

Learning objectives: learn the latest developments in science presented at the ESC Congress 2014 in Barcelona, Spain.

08:30   Introduction - F. Pinto (Lisbon, Portugal) & Dr Sim (APSC President)

08:35  Heart failure cardiomyopathy - M. Komajda (Paris, France)

09:00   Arrhythmias - R. Ferrari (Ferrara, Italy)

09:20   Valve disease - J. Bax (Leiden, Netherlands)

09:45   Discussion - Dr Sim (APSC President)

10:00   End of session


10:00 - 10:30     Coffee Break

10:30- 11:30 ESC Guidelines: an update Part I

Boehringer Ingelheim supports the session "ESC Guidelines an update part I" with an unrestricted educational grant. Boehringer Ingelheim does not affect or contribute to the scientific content of this session

Chairpersons: M. Komajda (Paris, France), Dr Sim (APSC President)


Learning objectives: learn through interactive clinical cases discussions  the key points developed in ESC Guidelines on the management of atrial fibrillation, on myocardial revascularization and on peri-operative management of cardiac patients undergoing non cardiac surgery.


10:30  A cardiac patient undergoing colectomy - J. Bax (Leiden, Netherlands)

10:45  Discussion - Dr Sim (APSC President)

11:00  What do ESC Guidelines say? - J. Bax (Leiden, Netherlands)

11:15  Discussion - Dr Sim (APSC President)

11:30  End of session


Room ICC Hall 1

17:30-18:30 Heart rate reduction: questions and answers in the management of Heart Failure & Angina - Satellite Symposium sponsored by SERVIER

Chairperson: N. Bazargani (Dubai, UAE)

17:30    Each step in the heart failure patient's journey counts - M. Komajda (Paris, France)

18:00    Management of Angina: from symptoms relief to improving cardiac efficiency - R. Ferrari (Ferrara, Italy)

Friday 1 May

Room ICC Hall 2

08:30 - 10:00 - Take home messages from ESC Congress 2014- Part II

Chairpersons: R Ferrari (Ferrara, Italy), J. Tan (Sinapore)

Learning objectives: learn the latest developments in science presented at the ESC Congress 2014 in Barcelona, Spain.

08:30   Imaging - F. Pinto (Lisbon, Portugal)

09:00   Interventional cardiology - S. Kristensen (Aarhus, Denmark)

09:30   Risk factors - M. Komajda (Paris, France)

09:45   Discussion - J. Tan (Singapore)

10:00 - 10:30     Coffee Break

 

10:30 -12:00  ESC Guidelines: an update Part II

Chairpersons: F. Pinto (Lisbon, Portugal), P. Laothavorn (Thailand)

Learning objectives: Learn through interactive clinical cases discussions  the key points developed in ESC Guidelines on the management of atrial fibrillation, on myocardial revascularization and on peri-operative management of cardiac patients undergoing non cardiac surgery.


10:30  A patient with new onset atrial fibrillation - R. Ferrari (Ferrara, Italy)

10:40  Discussion - P. Laothavorn (Thailand)

10:50  What do ESC Guidelines say? - R. Ferrari (Ferrara, Italy)

11:20  Clinical Case: A diabetic patient undergoing revascularization - S. Kristensen (Aarhus, Denmark)

11:30  Discussion - P. Laothavorn (Thailand)

11:40  What do ESC Guidelines say? - S. Kristensen (Aarhus, Denmark)

11:50  Discussion - P. Laothavorn (Thailand)


Room ICC Hall 1

13:00-14:00 NOACs in practice - Satellite Symposium sponsored by Bayer HealthCare Pharmaceuticals

Chairpersons: M. Aljarrlah (Kuwait)

13:00    Personalizing NOACS for Different patients population - R.Cappato (Milan, Italy)
13:20    Practical Guide lines Recommendations (EHRA-ESC updates) - J.Camm (London, United Kingdom)
13:40    Q&A - All

 

ESC Faculty

Prof. Fausto Pinto, FESC (Lisbon, Portugal)

ESC President(2014 – 2016), Fausto Pinto is currently the Head of Cardiology Department at Santa Maria University Hospital, CHLN, E.P.E. in Lisbon, Portugal, Full Professor of Cardiology and Chair of Cardiology Clinic at Lisbon University Medical School in Lisbon, Portugal, Director of the Lisbon Cardiovascular Institute, President of the Association for Research and Development of the Faculty of Medicine. He is the Editor in Chief of the Portuguese Journal of Cardiology (since 1999), member of the Editorial of Board of several international peer-reviewed journals and an Expert Reviewer for the European Commission. His main areas of interest are in cardiovascular imaging, particularly on the use of ultrasound in cardiology.

Prof. Michel Komajda, FESC (Paris, France)

ESC Past president (2010 - 2012), Michel Komajda serves as a Professor of Cardiology in the Department of Cardiology at University Pierre and Marie Curie and Pitie Salpetriere Hospital in France. He has been on the steering committee for many major cardiovascular trials throughout his career; most recently CARMEN, COMET, I-PRESERVE, HEAAL, SHIFT, and RECORD. His main fields of interest are pharmacology of heart failure; neuro-hormones in heart failure and genetics of dilated and hypertrophic cardiomyopathy.

Prof. Roberto Ferrari, FESC (Ferrara, Italy)

prof. Ferrari, FESCESC Past president (2008-2010), Roberto Ferrari serves as Professor of Cardiology at the University hospital of Ferrara. He is currently Editor of Dialogues in Cardiovascular Medicine and the European Heart Journal Supplement – the Heart of the Matter.  His research interests concern the characterization of the molecular mechanisms of the ischemic and failing myocardium and the clinical treatment of myocardial ischemia and heart failure, with a particular emphasis on interdisciplinary and collaborative studies. He is also President of European Heart for Children.

 

 

Prof. Jeroen Bax, FESC (Leiden, Netherlands)

ESC President-Elect (2014 – 2016), Jeroen Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center. His main interests include clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations, as well as serving on the editorial boards of many different journals. 

Steen Dalby Kristensen, FESC (Aarhus, Denmark)

Professor Kristensen is a specialist in Cardiology and Internal Medicine, an interventional Cardiologist and Head of the Cardiovascular Research Centre in the Department of Cardiology at Aarhus University Hospital. He has a particular interest in acute coronary syndromes and antithrombotic therapy and is leading a research group on platelets and coronary thrombosis. Author and co-author of more than 230 scientific papers and book chapters, he is also the editor of five books and editor of European Heart Journal and Thrombosis and Haemostasis.


The ESC Global Scientific Activities is supported by Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim and SERVIER, in the form of an unrestricted educational grant.

Bayer       Servier